disitamab vedotin (dv) Search Results


disitamab vedotin dv  (RemeGen Ltd)
90
RemeGen Ltd disitamab vedotin dv
Major metabolic pathways of [ 3 H]-labelled <t>disitamab</t> <t>vedotin</t> in rats/mice. P: plasma, represented by rate, % in B: bile, U: urine, F: faeces, representing and stool, respectively, represented by dose, %; T: tumour tissue, represented by rate, % of F: female and M: male rats with tumour tissue
Disitamab Vedotin Dv, supplied by RemeGen Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/disitamab vedotin dv/product/RemeGen Ltd
Average 90 stars, based on 1 article reviews
disitamab vedotin dv - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Major metabolic pathways of [ 3 H]-labelled disitamab vedotin in rats/mice. P: plasma, represented by rate, % in B: bile, U: urine, F: faeces, representing and stool, respectively, represented by dose, %; T: tumour tissue, represented by rate, % of F: female and M: male rats with tumour tissue

Journal: ADMET & DMPK

Article Title: Preclinical pharmacokinetics, distribution, metabolism and excretion of disitamab vedotin

doi: 10.5599/admet.2582

Figure Lengend Snippet: Major metabolic pathways of [ 3 H]-labelled disitamab vedotin in rats/mice. P: plasma, represented by rate, % in B: bile, U: urine, F: faeces, representing and stool, respectively, represented by dose, %; T: tumour tissue, represented by rate, % of F: female and M: male rats with tumour tissue

Article Snippet: Disitamab vedotin (DV), developed by RemeGen.

Techniques: Clinical Proteomics